Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Patient Capital Management 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Patient Capital Management)

Primary Source Intelligence • Q2 2024 Letter Analysis

Patient Capital Management Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Patient Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

YTD+9.6%

Annualized+7.6%

Digest Analysis

Quick Take

"Patient Capital underperformed in Q2 as small caps lagged mega-cap tech, but maintains conviction in unloved value opportunities. Portfolio concentrated in small-to-mid cap names, travel, and healthcare while avoiding AI bubble."

Executive Summary

Patient Capital's Opportunity Equity declined 1.9% net in Q2 2024, bringing year-to-date returns to 9.6% as smaller cap and low multiple names dragged performance in a market dominated by large cap technology. The fund maintains conviction in its strategy of buying quality businesses at attractive valuations in unloved areas while the market chases AI and quality compounders to extreme valuations. More than half the portfolio consists of small-to-mid cap, healthcare, and travel names that have lagged but offer compelling long-term opportunities. Key holdings include Nvidia (trimmed after doubling), energy play Kosmos Energy, travel names like Expedia and Delta Airlines, and healthcare companies like Illumina and Biogen. The manager sees growing recession risks from Fed policy but expects rate cuts later this year could benefit laggards significantly. With the economy slowing and market concentration at extremes, the fund is positioned for a potential rotation away from mega-cap technology toward undervalued smaller companies with solid fundamentals.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

High conviction score based on concentrated portfolio with 12 named positions, specific price targets (IAC worth $90, KOS worth double), detailed fundamental analysis, and explicit 5-year conviction statement. Manager provides specific investment rationale and sizing decisions for each holding.

Growth Outlook

38%

BearishBullish

Neutral (38%)

Manager acknowledges slowing economy, recession risks, and AI bubble concerns but maintains base case for rate cuts leading to market gains. Mixed outlook with cautious optimism tempered by meaningful downside risks.

Risk Appetite

43%

DefensiveAggressive

Balanced (43%)

Portfolio leverage was reduced early in quarter due to recession risks, but manager continues building small cap positions and adding new names. Selective risk-taking with defensive adjustments.

Capital Deployment

40%

De-riskingDeploying

Net Neutral (40%)

Portfolio leverage was reduced early in quarter representing de-risking, though manager continues selectively adding to existing small cap names and initiating new positions like Everi. Net modest de-risking despite continued selective deployment.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

Manager plans to continue buying quality businesses at attractive valuations in unloved areas, watching for opportunities. Mild deployment bias despite economic concerns, with flexibility on timing.

Language Signal

5%

BearishBullish

Bearish (5%)

Balanced language with opportunity terms like attractive valuations and compelling opportunities offset by risk language around recession, bubble, and economic weakness. Slightly more opportunity-focused overall.

Perceived Risk

75%

Low RiskElevated

Elevated Risk (75%)

High perceived risk with detailed discussion of recession indicators (Sahm rule triggered, GDP slowing, unemployment rising), Fed policy error risks, AI bubble concerns, and market concentration risks. Multiple systemic risks identified with specific metrics.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Manager sees compelling opportunities in unloved small caps and specific sectors like travel and healthcare, but notes difficulty finding opportunities elsewhere. Selective environment requiring patience but with identified pockets of value.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Explicit 5-year conviction statement and emphasis on long-term fundamental analysis. Manager willing to hold through short-term volatility and focuses on multi-year thesis realization rather than near-term catalysts.